Delivery Order SPE2DB20D1100-SPE2DB24FC2C0
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Advair HFA 115-21 MCG Inhaler 12GM. The contract has a ceiling value of $19,671.08 and is a delivery order that runs through August 12, 2024. It is a firm-fixed-price contract with no set-aside designation. AmerisourceBergen holds several large Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, such as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Advair HFA 115-21 mcg inhaler 12 gm. The contract has a ceiling value of $7,803.44 and is structured as a firm-fixed-price delivery order with a performance period extending to May 7, 2025. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This federal contract award, valued at $1,315.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Advair HFA 45-21 MCG Inhaler 12GM, a pharmaceutical product. This award is not associated with any set-aside designation, indicating open competition. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,122.46, is a delivery order for the supply of an Advair HFA 45-21 MCG Inhaler 12GM, a pharmaceutical product. The contract has a completion date of January 28, 2025 and is a firm fixed-price arrangement. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of an Advair HFA 230-21 mcg inhaler product. The Delivery Order contract, valued at $1,987.86, is a Firm Fixed Price arrangement with a completion date of May 22, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued up to $999,999,999.00...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,326.74 firm fixed-price delivery order is for the supply of Advair HFA 115-21 MCG Inhaler 12GM, a pharmaceutical product, to support military healthcare programs. The contract has a completion date of February 21, 2024 and was awarded on February 20, 2024. The award is not associated with a set-aside program....
- This federal contract award, valued at $4,964.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Advair HFA 230-21 mcg Inhaler 12gm, a pharmaceutical product. The contract has a firm fixed price structure and an ultimate completion date of March 27, 2025. While the original solicitation is not provided, the award indicates that Amerisourcebergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,383.22, is a Firm Fixed Price Delivery Order for the supply of Advair HFA 115-21 MCG Inhaler (12 GM). The contract has an ultimate completion date of May 29, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999...
- This federal contract award is a delivery order placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $4,270.22, is for the supply of Advair HFA 230-21 MCG Inhaler 12GM, a critical pharmaceutical product. The contract has an ultimate completion date of November 13, 2024 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Advair HFA 115-21 MCG Inhaler 12GM. The contract is a Delivery Order with a firm fixed price of $1,639.62 and a performance period ending on May 1, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FC2C0Delivery Order
This federal contract award, SPE2DB20D1100|SPE2DB24FC2C0, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Advair HFA 230-21 MCG Inhaler 12GM, a pharmaceutical product, and has a firm fixed price ceiling value of $18,564.59. The contract is a delivery order that has an ultimate completion date of June 11, 2024. This award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.6k | 6/10/24 |